|
|
Volumn 362, Issue 9387, 2003, Pages 919-920
|
|
Heart failure: Treatment and ethnic origin [5] (multiple letters)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE;
ANTIDIABETIC AGENT;
BIGUANIDE DERIVATIVE;
ELECTROLYTE;
INSULIN;
LACTIC ACID;
METFORMIN;
PHENFORMIN;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
PYRUVIC ACID;
CARDIOVASCULAR RISK;
DRUG APPROVAL;
DRUG EFFECT;
DRUG INDICATION;
DRUG MARKETING;
DRUG SAFETY;
DYSLIPIDEMIA;
ELECTROLYTE DISTURBANCE;
ETHNOLOGY;
GLUCONEOGENESIS;
HEART FAILURE;
HUMAN;
HYPERINSULINEMIA;
HYPERTENSION;
INSULIN SENSITIVITY;
LACTATE BLOOD LEVEL;
LACTIC ACIDOSIS;
LETTER;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
TREATMENT CONTRAINDICATION;
UNITED STATES;
CHEMICALLY INDUCED DISORDER;
CONGESTIVE HEART FAILURE;
DRUG CONTRAINDICATION;
ETHNIC GROUP;
NOTE;
AGE;
AGED;
ASIA;
CENTRAL AMERICA;
CORONARY ARTERY DISEASE;
DIABETES MELLITUS;
METHODOLOGY;
MIDDLE AGED;
MINORITY GROUP;
RISK FACTOR;
STATISTICS;
UNITED KINGDOM;
ACIDOSIS, LACTIC;
DIABETES MELLITUS, TYPE 2;
ETHNIC GROUPS;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYPOGLYCEMIC AGENTS;
METFORMIN;
AGE FACTORS;
AGED;
ASIA;
CARIBBEAN REGION;
CORONARY DISEASE;
DIABETES COMPLICATIONS;
GREAT BRITAIN;
HYPERTENSION;
MIDDLE AGED;
MINORITY GROUPS;
RESEARCH DESIGN;
RISK FACTORS;
|
|
EID: 0347657163
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(03)14316-4 Document Type: Letter |
|
Times cited : (5)
|
|
References (4)
|
